These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 31239068)

  • 1. Invasive lobular breast cancer: A review of pathogenesis, diagnosis, management, and future directions of early stage disease.
    Thomas M; Kelly ED; Abraham J; Kruse M
    Semin Oncol; 2019 Apr; 46(2):121-132. PubMed ID: 31239068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive lobular breast cancer and its variants: how special are they for systemic therapy decisions?
    Guiu S; Wolfer A; Jacot W; Fumoleau P; Romieu G; Bonnetain F; Fiche M
    Crit Rev Oncol Hematol; 2014 Dec; 92(3):235-57. PubMed ID: 25129506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Issues Affecting the Loco-regional and Systemic Management of Patients with Invasive Lobular Carcinoma of the Breast.
    Jacobs C; Clemons M; Addison C; Robertson S; Arnaout A
    Breast J; 2016; 22(1):45-53. PubMed ID: 26782951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative effectiveness of adjuvant chemotherapy for invasive lobular compared with invasive ductal carcinoma of the breast.
    Marmor S; Hui JYC; Huang JL; Kizy S; Beckwith H; Blaes AH; Rueth NM; Tuttle TM
    Cancer; 2017 Aug; 123(16):3015-3021. PubMed ID: 28382636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is pleomorphic lobular carcinoma really a distinct clinical entity?
    Buchanan CL; Flynn LW; Murray MP; Darvishian F; Cranor ML; Fey JV; King TA; Tan LK; Sclafani LM
    J Surg Oncol; 2008 Oct; 98(5):314-7. PubMed ID: 18668643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive Pleomorphic Lobular Histology Is an Adverse Prognostic Factor on Survival in Patients with Breast Cancer.
    Sahin S; Karatas F; Erdem GU; Hacioglu B; Altundag K
    Am Surg; 2017 Apr; 83(4):359-364. PubMed ID: 28424130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment choices for patients with invasive lobular breast cancer: a doctor survey.
    Jacobs C; Ibrahim MF; Clemons M; Hutton B; Simos D; Caudrelier JM; Graham ID; Smith S; Addison C; Arnaout A
    J Eval Clin Pract; 2015 Aug; 21(4):740-8. PubMed ID: 26059404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the clinicopathological features of invasive ductal, invasive lobular, and mixed (invasive ductal + invasive lobular) carcinoma of the breast.
    Zengel B; Yararbas U; Duran A; Uslu A; Elıyatkın N; Demırkıran MA; Cengiz F; Şimşek C; Postacı H; Vardar E; Durusoy R
    Breast Cancer; 2015 Jul; 22(4):374-81. PubMed ID: 23925582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does routine grading of invasive lobular cancer of the breast have the same prognostic significance as for ductal cancers?
    Sinha PS; Bendall S; Bates T
    Eur J Surg Oncol; 2000 Dec; 26(8):733-7. PubMed ID: 11087636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased incidence of lobular breast cancer in women treated with hormone replacement therapy: implications for diagnosis, surgical and medical treatment.
    Biglia N; Mariani L; Sgro L; Mininanni P; Moggio G; Sismondi P
    Endocr Relat Cancer; 2007 Sep; 14(3):549-67. PubMed ID: 17914088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast Cancer.
    Truin W; Vugts G; Roumen RM; Maaskant-Braat AJ; Nieuwenhuijzen GA; van der Heiden-van der Loo M; Tjan-Heijnen VC; Voogd AC
    Ann Surg Oncol; 2016 Jan; 23(1):51-7. PubMed ID: 25980321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Yale University experience of early-stage invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) treated with breast conservation treatment (BCT): analysis of clinical-pathologic features, long-term outcomes, and molecular expression of COX-2, Bcl-2, and p53 as a function of histology.
    Moran MS; Yang Q; Haffty BG
    Breast J; 2009; 15(6):571-8. PubMed ID: 19995377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Pathologic Finding of Combined Lobular Carcinoma
    Jean-Louis CJ; Masdon J; Smith B; Battles O; Dale P
    Am Surg; 2017 May; 83(5):482-485. PubMed ID: 28541858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma.
    Vo TN; Meric-Bernstam F; Yi M; Buchholz TA; Ames FC; Kuerer HM; Bedrosian I; Hunt KK
    Am J Surg; 2006 Oct; 192(4):552-5. PubMed ID: 16978974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma.
    Adachi Y; Ishiguro J; Kotani H; Hisada T; Ichikawa M; Gondo N; Yoshimura A; Kondo N; Hattori M; Sawaki M; Fujita T; Kikumori T; Yatabe Y; Kodera Y; Iwata H
    BMC Cancer; 2016 Mar; 16():248. PubMed ID: 27015895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Long-term Study of a Large Series of Patients with Invasive Ductal Carcinoma and Invasive Lobular Carcinoma. Loco-Regional Recurrence, Metastasis, and Survival.
    García-Fernández A; Lain JM; Chabrera C; García Font M; Fraile M; Barco I; Torras M; Reñe A; González S; González C; Piqueras M; Veloso E; Cirera L; Pessarrodona A; Giménez N
    Breast J; 2015; 21(5):533-7. PubMed ID: 26190560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor microenvironment in invasive lobular carcinoma: possible therapeutic targets.
    Nakagawa S; Miki Y; Miyashita M; Hata S; Takahashi Y; Rai Y; Sagara Y; Ohi Y; Hirakawa H; Tamaki K; Ishida T; Watanabe M; Suzuki T; Ohuchi N; Sasano H
    Breast Cancer Res Treat; 2016 Jan; 155(1):65-75. PubMed ID: 26715212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma.
    Hogan MP; Goldman DA; Dashevsky B; Riedl CC; Gönen M; Osborne JR; Jochelson M; Hudis C; Morrow M; Ulaner GA
    J Nucl Med; 2015 Nov; 56(11):1674-80. PubMed ID: 26294295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of invasive lobular carcinoma on long-term outcomes in Mexican breast cancer patients.
    Flores-Díaz D; Arce C; Flores-Luna L; Reynoso-Noveron N; Lara-Medina F; Matus JA; Bargallo-Rocha E; Pérez V; Villarreal-Garza C; Cabrera-Galeana P; Mohar A
    Breast Cancer Res Treat; 2019 Jul; 176(1):243-249. PubMed ID: 30997623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel Lymph Node Biopsy and Isolated Tumor Cells in Invasive Lobular Versus Ductal Breast Cancer.
    Truin W; Roumen RM; Siesling S; van der Heiden-van der Loo M; Lobbezoo DJ; Tjan-Heijnen VC; Voogd AC
    Clin Breast Cancer; 2016 Aug; 16(4):e75-82. PubMed ID: 27116948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.